Pfizer net income jumps

Comment on this story
Pfizer1 Reuters. US drugmaker Pfizer.

Pfizer Inc. says its second-quarter net income jumped 25 percent as sharply lower production, marketing and restructuring costs more than offset a plunge in revenue from cholesterol fighter Lipitor caused by generic competition.

The world's biggest drugmaker easily beat Wall Street expectations. Pfizer's stock rose 55 cents, or 2.3 percent, to $24.26 in premarket trading.

The Viagra maker says its net income was $3.25 billion, or 43 cents per share, up from $2.61 billion, or 33 cents per share, a year earlier.

Excluding one-time items, adjusted net income was $4.67 billion, or 62 cents per share. That beat Wall Street expectations for 54

cents per share.

Revenue totaled $15.06 billion, down 9 percent from $16.49 billion a year ago. It still topped expectations for $149.93 billion, according to FactSet. - Sapa-AP


sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines